The Recall Desk
ModerateFDA (Drugs)·D-0470-2023·Announced 2023-03-29

Daytrana Methylphenidate Patches Recalled for Defective Delivery System

Noven Pharmaceuticals is recalling specific lots of Daytrana methylphenidate transdermal patches distributed nationwide because the delivery system is out of specification for shear. The affected lots require patient and healthcare provider attention.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing defect in the delivery system specification, a product quality issue rather than a direct safety threat to patient health.

Plain-English summary

Noven Pharmaceuticals Inc is recalling specific lots of Daytrana (methylphenidate transdermal system) 10mg patches due to a defective delivery system that is out of specification for shear.

The affected lots are #91955 (expiration 7/2023) and #93039 (expiration 10/2023). Distribution was nationwide in the United States. Package NDC is 68968-5552-3.

Patients using Daytrana patches should verify the lot number on their medication carton. Those with patches from the affected lots should contact their healthcare provider or pharmacist for guidance on next steps.

The recalled product

Product
DAYTRANA (METHYLPHENIDATE)
Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals Inc
Category
Drug — Transdermal / Prescription Stimulant
Hazard
  • drug-delivery-failure
  • adhesion-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot#: 91955
  • Exp. 7/2023
  • 93039
  • Exp. 10/2023

Distribution

Distributed nationwide across the United States.

Related recalls

Same brand · DAYTRANA

Same category